Aerogen, Inc.

Pharmaceutical company gets Nasdaq listing determination

Published in Lab Business Week, July 3rd, 2005

Aerogen, Inc., (AEGN) announced that it has appealed the May 25, 2005, decision of the Nasdaq Listing Qualifications Staff to delist its common stock from The Nasdaq SmallCap Market by filing a request for a hearing before a Nasdaq Listing Qualifications Panel.

The company's stock will continue to be listed on The Nasdaq SmallCap Market until the hearing has been held and the panel has issued a decision. A hearing date has not yet been set, but Nasdaq rules require that the hearing be held within the next 45 days.

As previously reported on a Form 8-K filed with the Securities and Exchange Commission on April 25, 2005, the company received a letter...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2005-07-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry